Jacobi Capital Management LLC Esperion Therapeutics, Inc. Transaction History

Jacobi Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $961 - $2,384	-200 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$19.4 - $28.71 $5,820 - $8,613	-300 Reduced 60.0%	200 $4,000
Q1 2021 May 11, 2021	BUY	$25.12 - $36.89 $7,536 - $11,067	300 Added 150.0%	500 $14,000
Q2 2020 Aug 04, 2020	SELL	$30.04 - $51.31 $5,707 - $9,748	-190 Reduced 48.72%	200 $10,000
Q2 2020 Jul 27, 2020	BUY	$30.04 - $51.31 $5,707 - $9,748	190 Added 95.0%	390 $10,000

Q1 2020 Apr 24, 2020	BUY	$27.44 - $73.84 $5,488 - $14,768	200 New	200 $6,000

214

114M

643K

769K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $193M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.